Partial
Partially Aligned
Patient Risk:
Moderate
Summary
The claims generally align with the label’s intended use (diluting/dissolving drugs for IV/IM/subcutaneous use per manufacturer instructions) and the key warning about IV administration without a solute. However, multiple added details (e.g., saline and bacteriostatic water properties/composition, absence of preservatives/electrolytes, pharmacy/IV-bag preparation, and stability/compatibility rationale) are not supported by the provided label sections, lowering overall alignment.
Category Scores
Accurate Statements
Sterile water for injection is used to dilute or dissolve drugs for intravenous, intramuscular, or subcutaneous injection according to the manufacturer’s instructions.
INDICATIONS AND USAGE: indicated only for diluting or dissolving drugs for IV/IM/subcutaneous injection, according to manufacturer instructions.
Sterile water for injection is used to prepare IV, IM, and subcutaneous injection preparations.
INDICATIONS AND USAGE: diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection.
The amount of preparation used depends on vehicle concentration, dose, and route of administration as recommended by the manufacturer.
DOSAGE AND ADMINISTRATION: volume dependent on vehicle concentration, dose and route per manufacturer.
Unsupported Statements
Bacteriostatic water contains a preservative (bacteriostatic agent) intended to help prevent microbial growth.
No such composition statement is supported by the provided SWFI label sections.
Saline (0.9% sodium chloride) contains salt.
No saline composition statement is present in the provided label sections.
Some drugs require saline for compatibility or solubility, while others specify sterile water.
Compatibility/solubility comparison statements are not supported by the provided label sections.
Sterile water for injection contains no added preservative and no added electrolytes.
Composition negatives (no preservative; no electrolytes) are not supported by the provided label sections.
Sterile water for injection is used as the diluent step in a pharmacy or clinical setting.
Setting-specific operational use is not supported by the provided label sections.
Sterile water for injection is used to prepare solutions that will then be further diluted in an IV bag depending on medication instructions.
IV-bag workflow language is not supported by the provided label sections.
Use the exact diluent specified for the medicine being prepared because compatibility and stability depend on the diluent.
Compatibility/stability mechanistic rationale is not supported by the provided label sections.
Do not substitute different diluents (such as saline or bacteriostatic water) unless the label or pharmacy protocol allows it.
A direct substitution prohibition is not supported by the provided label sections.
Contradictions
Important Omissions
The label states a specific contraindication/requirement: Sterile Water for Injection, USP must be made approximately isotonic prior to use.
Importance:
Moderate
The label includes adverse reaction examples (e.g., febrile response; local tenderness; abscess; tissue necrosis or infection; venous thrombosis/phlebitis; extravasation) and specific management steps (discontinue infusion, evaluate patient, institute countermeasures, and retrieve/save unused vehicle if possible).
Importance:
Moderate
The label warning is specific: Intravenous administration of Sterile Water for Injection without a solute may result in hemolysis. The provided claims do not clearly restate this warning content.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Although the general intended use (diluting/dissolving drugs per manufacturer instructions) aligns with the label, several claims introduce unlabeled composition/compatibility/operational details and fail to capture key labeled safety requirements (isotonicity prior to use) and specific warning/adverse reaction management language.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Multiple statements are not supported by the provided label sections (notably composition/compatibility, IV-bag workflow, and substitution guidance), and key labeled safety requirements (isotonicity prior to use; specific hemolysis warning; detailed adverse reaction management) are omitted or not clearly reflected.
Suggested Improvement
Limit claims to what the provided label text supports: use as a vehicle for diluting/dissolving drugs for IV/IM/subcutaneous injection per manufacturer instructions; emphasize the labeled requirement to make SWFI approximately isotonic prior to use and the warning about IV administration without a solute; avoid composition or compatibility/stability rationales unless directly supported by the provided label text.